Susquehanna International Group, LLP Moderna, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Moderna, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 1,228,711 shares of MRNA stock, worth $31.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,228,711
Previous 2,123,708
42.14%
Holding current value
$31.5 Million
Previous $88.3 Million
60.55%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding MRNA
# of Institutions
848Shares Held
258MCall Options Held
22.4MPut Options Held
30.1M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$656 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$567 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$443 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$228 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...